$353 Million is the total value of Tamarack Advisers, LP's 53 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 65.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDT | Sell | MEDTRONIC PLCequity | $31,033,000 | -12.4% | 250,000 | -16.7% | 8.79% | +20.9% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INCequity | $27,776,000 | -2.7% | 6,400,000 | -23.4% | 7.87% | +34.3% |
| HSIC | Buy | HENRY SCHEIN INCequity | $23,370,000 | +206.9% | 315,000 | +186.4% | 6.62% | +323.8% |
| PCRX | Sell | PACIRA BIOSCIENCES INCequity | $21,845,000 | -43.3% | 360,000 | -34.5% | 6.19% | -21.7% |
| TPB | TURNING POINT BRANDS INCequity | $18,308,000 | -12.3% | 400,000 | 0.0% | 5.19% | +21.2% | |
| PDCO | Sell | PATTERSON COS INCequity | $14,435,000 | -41.3% | 475,000 | -38.3% | 4.09% | -19.0% |
| VRAY | Sell | VIEWRAY INCequity | $13,200,000 | +23.9% | 2,000,000 | -18.4% | 3.74% | +71.0% |
| ITGR | Buy | INTEGER HOLDINGS CORPequity | $12,717,000 | +6.4% | 135,000 | +4.0% | 3.60% | +46.9% |
| LNTH | Sell | LANTHEUS HOLDINGS INCequity | $12,438,000 | -37.1% | 450,000 | -51.4% | 3.52% | -13.1% |
| UNH | Buy | UNITEDHEALTH GROUP INCequity | $12,013,000 | +222.8% | 30,000 | +200.0% | 3.40% | +346.0% |
| ATRC | Sell | ATRICURE INCequity | $11,900,000 | -9.2% | 150,000 | -25.0% | 3.37% | +25.4% |
| VTRS | Buy | VIATRIS INCequity | $11,789,000 | +237.5% | 825,000 | +230.0% | 3.34% | +366.3% |
| UTHR | Sell | UNITED THERAPEUTICS CORPequity | $11,123,000 | -33.5% | 62,000 | -38.0% | 3.15% | -8.2% |
| STRM | STREAMLINE HEALTH SOLUTIONSequity | $8,728,000 | -13.7% | 4,930,882 | 0.0% | 2.47% | +19.2% | |
| BVS | Sell | BIOVENTUS INC - Aequity | $8,360,000 | -18.9% | 475,000 | -29.6% | 2.37% | +11.9% |
| CVS | Sell | CVS HEALTH CORPequity | $8,344,000 | -50.7% | 100,000 | -55.6% | 2.36% | -31.9% |
| MDRX | Sell | ALLSCRIPTS HEALTHCARE SOLUTIequity | $8,330,000 | -36.6% | 450,000 | -48.6% | 2.36% | -12.4% |
| MSON | Buy | MISONIX INCequity | $8,318,000 | +21.3% | 375,000 | +7.1% | 2.36% | +67.4% |
| CI | New | CIGNA CORPequity | $8,297,000 | – | 35,000 | +100.0% | 2.35% | – |
| AHCO | New | ADAPTHEALTH CORPequity | $8,223,000 | – | 300,000 | +100.0% | 2.33% | – |
| ANGO | Sell | ANGIODYNAMICS INCequity | $8,139,000 | +7.0% | 300,000 | -7.7% | 2.30% | +47.8% |
| SIBN | Sell | SI-BONE INCequity | $8,025,000 | -8.3% | 255,000 | -7.3% | 2.27% | +26.7% |
| RDNT | Sell | RADNET INCequity | $7,580,000 | -49.1% | 225,000 | -67.2% | 2.15% | -29.7% |
| ICUI | Sell | ICU MEDICAL INCequity | $6,997,000 | -51.3% | 34,000 | -51.4% | 1.98% | -32.8% |
| PHR | New | PHREESIA INCequity | $6,853,000 | – | 111,800 | +100.0% | 1.94% | – |
| Buy | DERMTECH INCequity | $5,612,000 | +31.6% | 135,000 | +60.7% | 1.59% | +81.7% | |
| ELY | Buy | CALLAWAY GOLF COMPANYequity | $5,565,000 | +156.8% | 165,000 | +103.7% | 1.58% | +255.0% |
| INNV | New | INNOVAGE HOLDING CORPequity | $3,005,000 | – | 141,000 | +100.0% | 0.85% | – |
| MSACU | Sell | MEDICUS SCIENCES ACQUISITI-Aequity | $2,863,000 | -51.6% | 296,636 | -50.6% | 0.81% | -33.1% |
| CNC | New | CENTENE CORPequity | $2,553,000 | – | 35,000 | +100.0% | 0.72% | – |
| ISEE | Sell | IVERIC BIO INCequity | $2,524,000 | -29.0% | 400,000 | -30.4% | 0.72% | -1.9% |
| PRGO | Buy | PERRIGO CO PLCequity | $2,293,000 | +126.6% | 50,000 | +100.0% | 0.65% | +212.5% |
| DGX | Sell | QUEST DIAGNOSTICS INCequity | $1,980,000 | -89.7% | 15,000 | -90.0% | 0.56% | -85.8% |
| Buy | IWM US 08/20/21 P220put | $1,590,000 | +39650.0% | 5,000 | +25.0% | 0.45% | +44900.0% | |
| PLXS | Sell | PLEXUS CORPequity | $1,280,000 | -87.3% | 14,000 | -87.3% | 0.36% | -82.5% |
| AYRWF | Sell | AYR WELLNESS INCequity | $898,000 | -45.8% | 31,500 | -42.7% | 0.25% | -25.3% |
| CMIIU | Sell | CM LIFE SCIENCES II INCequity unit | $673,000 | -47.4% | 50,000 | -50.0% | 0.19% | -27.4% |
| New | ABT US 08/20/21 P120put | $670,000 | – | 1,000 | +100.0% | 0.19% | – | |
| BIO | New | BIO-RAD LABORATORIES-Aequity | $644,000 | – | 1,000 | +100.0% | 0.18% | – |
| New | HOLX US 12/17/21 C75call | $568,000 | – | 2,500 | +100.0% | 0.16% | – | |
| CERS | Sell | CERUS CORPequity | $443,000 | -50.9% | 75,000 | -50.0% | 0.12% | -32.4% |
| Buy | SPY US 07/16/21 P420put | $328,000 | +2.8% | 3,500 | +66.7% | 0.09% | +43.1% | |
| LH | Sell | LABORATORY CRP OF AMER HLDGSequity | $276,000 | -98.6% | 1,000 | -98.7% | 0.08% | -98.0% |
| Buy | BSX US 07/16/21 C42call | $258,000 | +115.0% | 2,000 | +100.0% | 0.07% | +192.0% | |
| New | BMY US 09/17/21 C70call | $245,000 | – | 2,500 | +100.0% | 0.07% | – | |
| Sell | ARKG US 07/16/21 P90put | $225,000 | -86.2% | 1,500 | -50.0% | 0.06% | -80.8% | |
| New | CTVA US 07/16/21 C44call | $158,000 | – | 1,500 | +100.0% | 0.04% | – | |
| New | PFE US 07/16/21 C40call | $84,000 | – | 3,500 | +100.0% | 0.02% | – | |
| Sell | GLD US 09/17/21 C200call | $70,000 | -91.1% | 5,000 | -37.5% | 0.02% | -87.7% | |
| MSACW | New | MEDICUS SCIENCES ACQ -CW27warrant | $67,000 | – | 66,665 | +100.0% | 0.02% | – |
| New | XLV US 07/16/21 P120put | $24,000 | – | 1,500 | +100.0% | 0.01% | – | |
| Exit | TTI210618C5.00call | $0 | – | -263 | -100.0% | 0.00% | – | |
| Exit | CALL LRCX APR 610.0000 04/01/2021call | $0 | – | -20 | -100.0% | -0.00% | – | |
| Exit | VTRS US 04/16/21 C21call | $0 | – | -3,000 | -100.0% | -0.00% | – | |
| Exit | CALL FB APR 305.0000 04/16/2021call | $0 | – | -100 | -100.0% | -0.01% | – | |
| MTW | Exit | MANITOWOC COMPANY INCequity | $0 | – | -2,500 | -100.0% | -0.01% | – |
| Exit | MDT US 04/16/21 C125call | $0 | – | -2,500 | -100.0% | -0.01% | – | |
| Exit | XLY210401C150.00call | $0 | – | -50 | -100.0% | -0.02% | – | |
| Exit | XLB210401C70.00call | $0 | – | -100 | -100.0% | -0.02% | – | |
| MCFT | Exit | MASTERCRAFT BOAT HOLDINGS INCequity | $0 | – | -4,500 | -100.0% | -0.02% | – |
| HMHC | Exit | HOUGHTON MIFFLIN HARCOURT COequity | $0 | – | -20,000 | -100.0% | -0.03% | – |
| RYI | Exit | RYERSON INCequity | $0 | – | -10,000 | -100.0% | -0.04% | – |
| Exit | TNDM US 04/16/21 P80put | $0 | – | -3,500 | -100.0% | -0.04% | – | |
| FSLR | Exit | FIRST SOLAR INCequity | $0 | – | -2,500 | -100.0% | -0.04% | – |
| SONO | Exit | SONOS INCequity | $0 | – | -7,000 | -100.0% | -0.05% | – |
| Exit | TLT US 05/21/21 C145call | $0 | – | -5,500 | -100.0% | -0.06% | – | |
| Exit | CVS US 04/16/21 C73call | $0 | – | -1,000 | -100.0% | -0.06% | – | |
| CCJ | Exit | CAMECO CORPequity | $0 | – | -20,000 | -100.0% | -0.07% | – |
| CALX | Exit | CALIX NETWORKS INCequity | $0 | – | -10,000 | -100.0% | -0.07% | – |
| Exit | CTLT US 04/16/21 P120put | $0 | – | -250 | -100.0% | -0.07% | – | |
| AAT | Exit | AMERICAN ASSETS TRUST INCequity | $0 | – | -12,000 | -100.0% | -0.08% | – |
| NOC | Exit | NORTHROP GRUMMAN CORPequity | $0 | – | -1,200 | -100.0% | -0.08% | – |
| Exit | XBI US 04/16/21 P140put | $0 | – | -1,000 | -100.0% | -0.13% | – | |
| OPTN | Exit | OPTINOSE INCequity | $0 | – | -175,000 | -100.0% | -0.13% | – |
| Exit | JNJ US 04/16/21 C160call | $0 | – | -1,500 | -100.0% | -0.17% | – | |
| Exit | TERRASCEND CORPequity | $0 | – | -125,000 | -100.0% | -0.26% | – | |
| XERS | Exit | XERIS PHARMACEUTICALS INCequity | $0 | – | -350,000 | -100.0% | -0.32% | – |
| EVH | Exit | EVOLENT HEALTH INC - Aequity | $0 | – | -125,000 | -100.0% | -0.52% | – |
| INMD | Exit | INMODE LTDequity | $0 | – | -62,850 | -100.0% | -0.93% | – |
| HEC | Exit | HUDSON EXECUTIVE INVEST-CL Aequity | $0 | – | -500,000 | -100.0% | -1.02% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCequity | $0 | – | -25,000 | -100.0% | -1.10% | – |
| HCA | Exit | HCA HEALTHCARE INCequity | $0 | – | -30,000 | -100.0% | -1.16% | – |
| NUAN | Exit | NUANCE COMMUNICATIONS INCequity | $0 | – | -225,000 | -100.0% | -2.01% | – |
| LMNX | Exit | LUMINEX CORPequity | $0 | – | -478,327 | -100.0% | -3.13% | – |
| HOLX | Exit | HOLOGIC INCequity | $0 | – | -275,000 | -100.0% | -4.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.